person

Sini L.

Country
Finland
Department
Helsinki University Hospital, Comprehensive Cancer Centre

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
46
Sites with multiple studies

Has run more than one trial at 46 of 170 partner sites.

Specializations

Hematologic Oncology

The investigator specializes in the treatment of multiple myeloma, with particular emphasis on managing cases that have shown resistance to previous treatments or experienced disease recurrence.

  • Relapsed/Refractory Multiple Myeloma
  • Novel Therapeutic Combinations
  • Disease Progression Management

Their research focuses on evaluating innovative therapeutic approaches for patients with refractory multiple myeloma, exploring combinations of established and emerging treatments.

Treatment Innovation

The investigator explores novel drug combinations including immunomodulatory agents and proteasome inhibitors for blood cancer treatment.

  • Combination Therapy Approaches
  • Treatment Resistance
  • Therapeutic Innovation

Their work encompasses the evaluation of comparative treatment efficacy in resistant disease settings.

Clinical Outcomes

The investigator focuses on measuring progression-free survival and treatment effectiveness in advanced hematologic malignancies.

  • Disease Progression Assessment
  • Treatment Response Evaluation
  • Long-term Outcome Analysis

Their research emphasizes the assessment of therapeutic interventions in improving patient outcomes for blood cancer.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.